Sanofi (France) Diabetes Drug Wins EU Panel Recommendation
Sanofi has received a recommendation for European approval of once-daily Lyxumia for the treatment of adults with type 2 diabetes mellitus. The European Medicines Agency's Committee for Medicinal Prod…FDA Panel Backs Novo Nordisk A/S Diabetes Drugs
WASHINGTON, Nov. 8, 2012 /PRNewswire/ -- Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has complet…Tags: food and drug administration fda, metabolic drugs advisory committee, Nordisk, novo nordisk, panel, PRNewswire

